US cancer centers warn drug shortages continue, impacting different varieties of medications
NBC5
While a shortage of the chemotherapy drugs cisplatin and carboplatin has improved in the United States, some of the nation's largest cancer centers now report additional concerns related to drug shortages, a new report finds.
Among 28 large cancer centers across the country, 89% reported last month that at least one drug used to either treat cancer, its symptoms or the side effects of treatment was in short supply at their center, according to new survey results released Wednesday by the National Comprehensive Cancer Network.
That percentage has not changed much from last year, when about 86% of surveyed centers reported a shortage of at least one type of anti-cancer drug. But what has changed is specifically which cancer drugs are impacted.